MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,260 | -99.7% | 269,319 | +114.5% | 0.30% | +713.5% |
| Q3 2022 | $2,255,000 | +2684.0% | 125,544 | +1840.4% | 0.04% | +1750.0% |
| Q2 2022 | $81,000 | -70.7% | 6,470 | -68.8% | 0.00% | -33.3% |
| Q1 2022 | $276,000 | +54.2% | 20,722 | +80.8% | 0.00% | 0.0% |
| Q4 2021 | $179,000 | -21.5% | 11,460 | +12.9% | 0.00% | -50.0% |
| Q3 2021 | $228,000 | +212.3% | 10,150 | +184.6% | 0.01% | +500.0% |
| Q1 2021 | $73,000 | -62.2% | 3,567 | -49.1% | 0.00% | -83.3% |
| Q4 2020 | $193,000 | -49.1% | 7,014 | -61.9% | 0.01% | -62.5% |
| Q2 2020 | $379,000 | +673.5% | 18,387 | +181.7% | 0.02% | +433.3% |
| Q1 2020 | $49,000 | -38.0% | 6,526 | +28.6% | 0.00% | -57.1% |
| Q4 2019 | $79,000 | +54.9% | 5,073 | -47.9% | 0.01% | +133.3% |
| Q3 2019 | $51,000 | -15.0% | 9,741 | +46.3% | 0.00% | -25.0% |
| Q2 2019 | $60,000 | +1100.0% | 6,658 | +3229.0% | 0.00% | – |
| Q2 2018 | $5,000 | -91.7% | 200 | -95.8% | 0.00% | -100.0% |
| Q4 2017 | $60,000 | -74.2% | 4,741 | -68.6% | 0.01% | -57.9% |
| Q3 2017 | $233,000 | +1453.3% | 15,080 | +1043.3% | 0.02% | +850.0% |
| Q2 2017 | $15,000 | +275.0% | 1,319 | +312.2% | 0.00% | – |
| Q1 2017 | $4,000 | +300.0% | 320 | +220.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |